Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy (Q82419364)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

main subject

dilated cardiomyopathy

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

A Staudt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L R Herda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Trimpert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L Lubenow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Landsberger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Hummel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

L G Eckerle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

D Beug

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C Müller

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

W Hoffmann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K Weitmann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

K Klingel

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R Kandolf

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

H K Kroemer

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Greinacher

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S B Felix

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

6 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

452-458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20054293%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/clpt.2009.246

16 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

IgG receptor polymorphisms: risk factors for disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Predictors of outcome in patients with suspected myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021

Determining the Best Ventilatory Efficiency Measure to Predict Mortality in Patients with Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.246

7 January 2021